AI-assisted ECG to speed diagnosis and treatment of occlusion heart attacks under a pay-for-performance program
A Randomized Clinical Trial Investigating the Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System
This project will test whether adding an AI tool that flags ECGs for occlusion heart attacks and linking those alerts to a pay-for-performance program helps emergency department patients who get ECGs get diagnosed and treated faster and with better outcomes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 212000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | National Defense Medical Center, Taiwan Academic / other |
| Locations | 3 sites (Kaohsiung City, Taiwan and 2 other locations) |
| Trial ID | NCT06887699 on ClinicalTrials.gov |
What this trial studies
This prospective interventional program integrates an AI-ECG algorithm into the hospital information system at three Taiwanese hospitals to generate real-time alerts when an ECG suggests occlusion myocardial infarction. Alerts are combined with a pay-for-performance (P4P) pathway that provides financial incentives to promote timely confirmation and reperfusion. The study enrolls emergency department patients who receive at least one ECG and compares diagnostic timeliness, treatment metrics, clinical outcomes, and healthcare costs associated with the AI-P4P pathway. Patients whose ECGs occurred while the AI was inactive or who had coronary angiography within the prior 3 days are excluded.
Who should consider this trial
Good fit: Ideal candidates are emergency department patients at participating hospitals who receive at least one ECG and do not have a recent coronary angiography within the prior 3 days.
Not a fit: Patients who do not present to participating hospitals, do not receive an ECG, had ECGs while the AI system was inactive, or recently underwent coronary angiography are unlikely to benefit from the program.
Why it matters
Potential benefit: If successful, this approach could lead to faster diagnosis and treatment of occlusion myocardial infarction, improving clinical outcomes and potentially lowering overall care costs.
How similar studies have performed: AI-ECG tools have shown promise in detecting acute coronary findings in prior work, but combining real-time AI ECG alerts with a pay-for-performance program for occlusion myocardial infarction is a novel approach that has not been widely tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients in the emergency department * Patients received at least 1 ECG examination. Exclusion Criteria: * The patients received ECG at the period of inactive AI-ECG system. * Patients with a history of coronary angiography within the past 3 days.
Where this trial is running
Kaohsiung City, Taiwan and 2 other locations
- Kaohsiung Armed Forces General Hospital — Kaohsiung City, Taiwan, Taiwan (Recruiting)
- Taipei Municipal Wanfang Hospital — Taipei, Taiwan (Recruiting)
- Tri-Service General Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Principal investigator: Chin Lin, PhD — National Defense Medical Center
- Study coordinator: Chin Lin, PhD
- Email: xup6fup@mail.ndmctsgh.edu.tw
- Phone: +886-2-8792-3100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.